IGF2BP2

insulin like growth factor 2 mRNA binding protein 2, the group of RNA binding motif containing|MicroRNA protein coding host genes

Basic information

Region (hg38): 3:185643130-185825042

Links

ENSG00000073792NCBI:10644OMIM:608289HGNC:28867Uniprot:Q9Y6M1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • diabetes mellitus, noninsulin-dependent (No Known Disease Relationship), mode of inheritance: Unknown

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the IGF2BP2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the IGF2BP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
17
clinvar
1
clinvar
18
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 17 2 0

Variants in IGF2BP2

This is a list of pathogenic ClinVar variants found in the IGF2BP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-185645614-G-A not specified Uncertain significance (Aug 02, 2021)2241077
3-185649461-G-A not specified Uncertain significance (Jun 16, 2024)3285499
3-185652112-T-A Likely benign (May 31, 2018)745118
3-185657366-T-A not specified Uncertain significance (Feb 15, 2023)2459962
3-185658402-G-A not specified Uncertain significance (Feb 16, 2023)2485748
3-185672560-G-A not specified Uncertain significance (Mar 13, 2023)2467195
3-185672570-G-A not specified Uncertain significance (Mar 08, 2024)3108543
3-185672579-G-A not specified Uncertain significance (Jun 16, 2023)2604018
3-185672603-C-T not specified Uncertain significance (Jan 09, 2024)3108542
3-185672635-C-T not specified Uncertain significance (Jan 02, 2024)3108541
3-185672660-T-A not specified Uncertain significance (Feb 13, 2024)3108540
3-185675352-T-C not specified Likely benign (Oct 27, 2023)3108539
3-185675798-T-C not specified Uncertain significance (Mar 07, 2024)3108546
3-185689361-T-C not specified Uncertain significance (Mar 12, 2024)3108545
3-185689502-C-T not specified Uncertain significance (Oct 04, 2022)2231014
3-185689544-G-A not specified Uncertain significance (Mar 24, 2023)2509609
3-185689571-T-C not specified Uncertain significance (Sep 26, 2023)3108544
3-185689590-A-G not specified Uncertain significance (Dec 01, 2022)2383741
3-185692739-C-T not specified Uncertain significance (Apr 11, 2023)2509387
3-185793899-G-T Diabetes mellitus type 2, susceptibility to risk factor (Jun 01, 2007)2435
3-185824915-C-T not specified Uncertain significance (Dec 08, 2021)2352667

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
IGF2BP2protein_codingprotein_codingENST00000382199 16181318
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2390.7611257320161257480.0000636
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.912003540.5650.00002053905
Missense in Polyphen62147.870.419281746
Synonymous0.4081361420.9560.000009141168
Loss of Function4.10833.70.2370.00000188374

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009060.0000906
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004630.0000462
European (Non-Finnish)0.00008810.0000879
Middle Eastern0.000.00
South Asian0.0001010.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: RNA-binding factor that recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation (By similarity). Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. Binding is isoform-specific. Binds to beta- actin/ACTB and MYC transcripts. {ECO:0000250, ECO:0000269|PubMed:23640942, ECO:0000269|PubMed:9891060}.;
Pathway
Metabolism of RNA;Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA (Consensus)

Recessive Scores

pRec
0.216

Intolerance Scores

loftool
0.452
rvis_EVS
-0.76
rvis_percentile_EVS
13.33

Haploinsufficiency Scores

pHI
0.809
hipred
Y
hipred_score
0.685
ghis
0.602

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.801

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Igf2bp2
Phenotype

Gene ontology

Biological process
anatomical structure morphogenesis;negative regulation of translation;regulation of cytokine biosynthetic process;regulation of mRNA stability;mRNA transport
Cellular component
nucleus;cytoplasm;cytosol;cytoskeleton
Molecular function
RNA binding;mRNA 3'-UTR binding;protein binding;translation regulator activity;mRNA 5'-UTR binding